This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact 10 mg/ml oral solution (300 ml). The $2,558.34 firm fixed price contract has a period of performance through November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a broad range of pharmaceutical products and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,133.39, is for the delivery of Briviact 10 mg/ml oral solution, a neurological medication. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact 10 mg/mL oral solution. The contract has a ceiling value of $9,153.90 and a period of performance through April 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,671.40 firm fixed-price contract is for the delivery of the drug Briviact in 100 mg tablet form, with a period of performance through April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of Briviact 10 mg/ml oral solution, a prescription medication, and has a firm fixed price of $1,214.38. The contract has an ultimate completion date of June 25, 2024. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the drug Briviact 100 mg tablet in 60-count packages. The contract has a firm fixed price of $5,815.50 and a completion date of September 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the procurement of Briviact 100 mg tablets, a prescription medication. The contract has a Firm Fixed Price pricing type and a ceiling value of $5,613.58. The period of performance runs through January 17, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Briviact oral solution to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,558.34 firm-fixed-price delivery order contract has an ultimate completion date of August 27, 2024. The contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a specialty pharmaceutical product, Briviact 10 mg/ml oral solution 300 ml. The contract has a ceiling value of $3,411.16 and a performance period through March 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued up to...
This is a $5,578.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Briviact 10 mg/ml oral solution in 300 ml containers. The contract has an ultimate completion date of March 10, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...